Related Experiment Video

Updated: Oct 14, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.2K

Pediatric Inflammatory Multisystem Syndrome or Multisystem Inflammatory Syndrome in Children: A New Thread in

Víctor Arízaga-Ballesteros1, Marissa Andrea Gutierrez-Mendoza1, Kinoa Rina Villanueva-Sugishima1

  • 1Tecnológico de Monterrey, Monterrey, Mexico.

Global Pediatric Health
|November 4, 2021
PubMed

Insights

Pediatric inflammatory multisystem syndrome (PIMS) is a serious COVID-19 complication in children. This review covers PIMS epidemiology, clinical features, diagnosis, and treatment, including Latin American experiences.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Virology

Background:

  • The COVID-19 pandemic spurred global health efforts for SARS-CoV-2 prevention and treatment.
  • Pediatric inflammatory multisystem syndrome (PIMS) has emerged as a significant medium-term complication of COVID-19 in children.

Purpose of the Study:

  • To review current understanding of PIMS in children.
  • To detail PIMS epidemiology, clinical presentation, and evolution.
  • To outline diagnostic testing, interconsultation recommendations, and treatment strategies.

Main Methods:

  • Comprehensive literature review of PIMS.
  • Analysis of epidemiological data and clinical case studies.
  • Synthesis of current diagnostic and therapeutic guidelines.

Main Results:

  • PIMS definition, epidemiology, and clinical manifestations are presented.
  • Recommended laboratory tests, diagnostic imaging, and specialist consultations are detailed.
  • Treatment approaches and outcomes for PIMS are discussed, incorporating Latin American data.

Conclusions:

  • PIMS requires prompt recognition and multidisciplinary management.
  • Understanding PIMS evolution and treatment is crucial for pediatric COVID-19 care.
  • Further research on PIMS long-term outcomes is warranted.

Keywords:
Covid-19PIMSadolecentchildren

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.6K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
32
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
23
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
31
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
947